Drug Approval

FDA Clinical Trials FDA Regulations Regulatory Agencies Mifepristone Generic Drugs FDA Approval NHS Regulatory Affairs NHS Policies

3 ARTICLES

6h ago

Judge Pauses Texas-Florida Mifepristone Lawsuit Pending FDA Review

The court-ordered hold gives the Food and Drug Administration time to complete a retrospective safety review that could determine whether the drug stays on the market nationwide.

Stories older than 24h

10 ARTICLES

3d ago

FDA Approves Mounjaro to Lower Heart‑Attack and Stroke Risk in High‑Risk Type 2 Diabetes

6 ARTICLES

2mo ago

Italy Opens SSN Coverage for Cytisine Quit-Smoking Pill Now Available in Pharmacies

7 ARTICLES

5mo ago

Hims & Hers Soars as Novo Nordisk Reinstates Supply Deal for Ozempic and Wegovy

5 ARTICLES

6mo ago

EMA Backs Single-Dose Acoziborole for Gambiense Sleeping Sickness Outside EU

10 ARTICLES

6mo ago

NICE Recommends First Vitiligo Repigmentation Cream for NHS Use in England

3 ARTICLES

6mo ago

FDA Approves Vanda’s Bysanti for Bipolar I Mania and Schizophrenia

4 ARTICLES

6mo ago

Eli Lilly Builds $1.5 Billion Stockpile of Orforglipron as FDA Decision Nears

9 ARTICLES

6mo ago

Eli Lilly Jumps on GLP‑1 Momentum as 2026 Outlook Beats and Targets Rise

5 ARTICLES

7mo ago

Bristol Myers Gains Analyst Support as 2026 Catalysts Offset Patent-Cliff Worries

3 ARTICLES

7mo ago

Shareholder Law Firms Expand Probes of Corcept After FDA CRL for Relacorilant

6 ARTICLES

7mo ago

FDA Issues Second Rejection of Atara’s EBV+ PTLD Therapy Tabelecleucel

9 ARTICLES

8mo ago

FDA Approves Vanda’s Nereus, First New Motion Sickness Treatment in Over 40 Years

4 ARTICLES

8mo ago

Bristol Myers Enters 2026 With Eliquis Medicaid Pact, Opdivo Qvantig Rollout, and Divergent Analyst Views

8 ARTICLES

8mo ago

FDA Clears Wegovy Weight-Loss Pill, U.S. Launch Set for January

8 ARTICLES

8mo ago

FDA Clears First New Oral Gonorrhea Antibiotics in Over 30 Years

Drug Approval

Judge Pauses Texas-Florida Mifepristone Lawsuit Pending FDA Review

FDA Approves Mounjaro to Lower Heart‑Attack and Stroke Risk in High‑Risk Type 2 Diabetes

Anvisa Approves First Non‑Hormonal Drug for Menopausal Hot Flashes

Germany Approves Cannabis-Based Drug Exilby for Neuropathic Back Pain

Supreme Court Clears Path for Generic 'Skinny Labels' in Unanimous Hikma Ruling

FDA Expands Tzield Use to Delay Type 1 Diabetes in Children Ages 1 to 7

Italy Opens SSN Coverage for Cytisine Quit-Smoking Pill Now Available in Pharmacies

Hims & Hers Soars as Novo Nordisk Reinstates Supply Deal for Ozempic and Wegovy

EMA Backs Single-Dose Acoziborole for Gambiense Sleeping Sickness Outside EU

NICE Recommends First Vitiligo Repigmentation Cream for NHS Use in England

Never miss stories about

Drug Approval

FDA Approves Vanda’s Bysanti for Bipolar I Mania and Schizophrenia

Eli Lilly Builds $1.5 Billion Stockpile of Orforglipron as FDA Decision Nears

Eli Lilly Jumps on GLP‑1 Momentum as 2026 Outlook Beats and Targets Rise

Bristol Myers Gains Analyst Support as 2026 Catalysts Offset Patent-Cliff Worries

Shareholder Law Firms Expand Probes of Corcept After FDA CRL for Relacorilant

FDA Issues Second Rejection of Atara’s EBV+ PTLD Therapy Tabelecleucel

FDA Approves Vanda’s Nereus, First New Motion Sickness Treatment in Over 40 Years

Bristol Myers Enters 2026 With Eliquis Medicaid Pact, Opdivo Qvantig Rollout, and Divergent Analyst Views

FDA Clears Wegovy Weight-Loss Pill, U.S. Launch Set for January

FDA Clears First New Oral Gonorrhea Antibiotics in Over 30 Years

Never miss stories about

Drug Approval